Biofrontera Inc (NASDAQ:BFRI) does about 114.84K shares in volume on a normal day but saw 1375958 shares change hands in the recent trading day. The company now has a market cap of 6.28M USD. Its current market price is $0.66, marking an increase of 16.26% compared to the previous close of $0.57. The 52 week high reached by this stock is $2.22 whilst the lowest price level in 52 weeks is $0.54.
The consensus objective for the share price is $5.38, suggesting that the stock has a potential upside of 87.73% over the period.
FactSet Research has provided data showing that 2 brokerages have issued ratings for the stock. 0 analysts have rated it as a sell, while 0 advise that it is a overweight. 2 analysts have rated it as a buy and 0 have advised that investors hold their positions. The consensus recommendation rating is Buy and Wall Street’s advice is for investors to Strong Buy the stock.
The current price level is 0.49%, -10.38%, and -31.14% away from its SMA20, SMA50, and SMA200 respectively, with the BFRI price moving above the 50-day SMA on current market day. Biofrontera Inc (BFRI) stock is up 4.04% over the week and -7.67% over the past month. Its price is -39.01% year-to-date and -34.18% over the past year.
The company’s next earnings report forecasts estimating quarterly EPS at -0.39 and -1.02 for whole year. Expected sales for next quarter are $9.55M, which analysts say will come at $40.89M for the current fiscal year and next year at $47.88M. In addition, estimates put the company’s current quarterly revenue at an average of $8.3M.
To reach the target analysts have set, the stock logically needs to grow 87.73 percent from here.
Outstanding shares total 8.87M with insiders holding 13.47% of the shares and institutional holders owning 26.05% of the company’s common stock. The company has a return on investment of -234.92% and return on equity of -384.98%. The beta has a value of 0.30. Price to book ratio is 12.58 and price to sales ratio is 0.17.
